Piper Sandler & Co’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-981
Closed -$17K 33
2015
Q4
$17K Buy
+981
New +$17K 0.04% 22
2015
Q2
Sell
-7,000
Closed -$548K 156
2015
Q1
$548K Buy
+7,000
New +$548K 0.23% 41